Uncovering the pharmacology of the G protein-coupled receptor GPR40:: High apparent constitutive activity in guanosine 5'-O-(3-[35S] thio) triphosphate binding studies reflects binding of an endogenous agonist

被引:70
作者
Stoddart, Leigh A.
Brown, Andrew J.
Milligan, Graeme
机构
[1] Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] GlaxoSmithKline, Dept Screening & Compound Profiling, Harlow, Essex, England
关键词
D O I
10.1124/mol.106.031534
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In cells lacking expression of Ca2+-mobilizing G proteins, coexpression of human GPR40 and G alpha(q) allowed medium- and long-chain fatty acids to elevate intracellular [Ca2+]. This was also observed when human embryonic kidney (HEK) 293 cells were transfected with a GPR40-G alpha(q) fusion protein. The kinetic of elevation of intracellular [Ca2+] slowed with increasing fatty acid chain length, suggesting different ligand on-rates, whereas the addition of fatty acid-free bovine serum albumin reduced signals, presumably by binding the fatty acids. To allow effective ligand equilibration, GPR40-G alpha(q) was used in guanosine 5'-O-(3-[S-35]thio)triphosphate ([S-35]GTP gamma S) binding assays. After expression of GPR40-G alpha(q) in HEK293 cells and membrane preparation basal binding of [S-35]GTP gamma S in G alpha(q) immunoprecipitates was high and not elevated substantially by fatty acids. However, treatment of membranes with fatty acid-free bovine serum albumin reduced the basal [S-35]GTP gamma S binding in a concentration-dependent manner and allowed the responsiveness and pharmacology at GPR40 of each of the fatty acids thiazolidinediones and a novel small-molecule agonist to be uncovered. Membranes of rat INS-1E cells that express GPR40 endogenously provided similar observations. The high apparent constitutive activity of GPR40-G alpha(q) was also reversed by a small-molecule GPR40 antagonist, and basal [S-35]GTP gamma S binding was prevented by the selective G alpha(q)/G alpha(11) inhibitor YM-254890. The current studies provide novel insights into the pharmacology of GPR40 and indicate that G protein-coupled receptors which respond to fatty acids, and potentially to other lipid ligands, can be occupied by endogenous agonists before assay and that this may mask the pharmacology of the receptor and may be mistaken for high levels of constitutive activity.
引用
收藏
页码:994 / 1005
页数:12
相关论文
共 39 条
[1]   Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery [J].
Bond, RA ;
IJzerman, AP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :92-96
[2]   Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules [J].
Briscoe, Celia P. ;
Peat, Andrew J. ;
McKeown, Stephen C. ;
Corbett, David F. ;
Goetz, Aaron S. ;
Littleton, Thomas R. ;
McCoy, David C. ;
Kenakin, Terry P. ;
Andrews, John L. ;
Ammala, Carina ;
Fornwald, James A. ;
Ignar, Diane M. ;
Jenkinson, Stephen .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) :619-628
[3]   The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids [J].
Briscoe, CP ;
Tadayyon, M ;
Andrews, JL ;
Benson, WG ;
Chambers, JK ;
Eilert, MM ;
Ellis, C ;
Elshourbagy, NA ;
Goetz, AS ;
Minnick, DT ;
Murdock, PR ;
Sauls, HR ;
Shabon, U ;
Spinage, LD ;
Strum, JC ;
Szekeres, PG ;
Tan, KB ;
Way, JM ;
Ignar, DM ;
Wilson, S ;
Muir, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11303-11311
[4]   A family of fatty acid binding receptors [J].
Brown, AJ ;
Jupe, S ;
Briscoe, CP .
DNA AND CELL BIOLOGY, 2005, 24 (01) :54-61
[5]   The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids [J].
Brown, AJ ;
Goldsworthy, SM ;
Barnes, AA ;
Eilert, MM ;
Tcheang, L ;
Daniels, D ;
Muir, AI ;
Wigglesworth, MJ ;
Kinghorn, I ;
Fraser, NJ ;
Pike, NB ;
Strum, JC ;
Steplewski, KM ;
Murdock, PR ;
Holder, JC ;
Marshall, FH ;
Szekeres, PG ;
Wilson, S ;
Ignar, DM ;
Foord, SM ;
Wise, A ;
Dowell, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11312-11319
[6]   Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS [J].
Canals, Meritxell ;
Jenkins, Laura ;
Kellett, Elaine ;
Milligan, Graeme .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (24) :16757-16767
[7]   Measurement of agonist-dependent and -independent signal initiation of α1b-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein Gα11 [J].
Carrillo, JJ ;
Stevens, PA ;
Milligan, G .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) :1080-1088
[8]   The assessment of antagonist potency under conditions of transient response kinetics [J].
Christopoulos, A ;
Parsons, AM ;
Lew, MJ ;
El-Fakahany, EE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 382 (03) :217-227
[9]   Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist' [J].
Gardner, A ;
Mallet, PE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 530 (1-2) :103-106
[10]   Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: An example of nongenomic signaling [J].
Gardner, OS ;
Dewar, BJ ;
Graves, LM .
MOLECULAR PHARMACOLOGY, 2005, 68 (04) :933-941